Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19 - report from ESC2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Mikhail Kosiborod explains the findings of the Meta-Analysis, shows SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients. These findings do not support the use of SGLT2 inhibitors as standard care in this clinical setting. Video: https://medicaldigest.org/scientific-contents/interview:prospective-meta-analysis-sglt2-inhibitor-randomized-trials-covid-19

Episode metadata supplied by the publisher feed · Published Sep 12, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Prospective Meta-Analysis of SGLT2 Inhibitor Randomized Trials in COVID-19 - report from ESC2023

0:00 2:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 2 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 12, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!